findmyKOL

Sandra Taler, MD

Basic profile

Mayo Clinic

ORCIDNPI
RegionRochester, MN · MidwestSpecialtyNephrologyFocusNephrology
Last active 2010EmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding2004–2010Why? →

Sandra Taler is a Nephrology physician affiliated with Mayo Clinic. OpenAlex indexes 170 publications with 41,180 citations (h-index 57); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
170publications

Distinct works indexed by OpenAlex, matched via ORCID.

41,180citations

Total citations across indexed works.

57h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
2NIH grants · 2004–2010

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.8%
    Thiazide-like diuretic20.6%
    Indapamide78%Chlorthalidone22%
    Part D43 patients
    Angiotensin receptor blocker (ARB)12.6%
    Losartan Potassium71%Irbesartan15%Valsartan14%
    Part D<11 patients

    + 8 more classes in this area

  • Metabolism & gastrointestinal

    9.5%
    Corticosteroid5.8%
    Prednisone100%
    Part D23 patients
    Proton pump inhibitor1.9%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 1 more class in this area

  • Hormonal (systemic)

    3.9%
    l-Thyroxine3.9%
    Levothyroxine Sodium100%
    Part D11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 20042010 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”